Published In

Substance Abuse

Document Type

Article

Publication Date

5-3-2023

Abstract

Patients receiving buprenorphine for the treatment of opioid use disorder (OUD) experience a roughly 50% reduction in mortality risk relative to those not receiving medication. Longer periods of treatment are also associated with improved clinical outcomes. Despite this, patients often express desires to discontinue treatment and some view taper as treatment success. Little is known about the beliefs and medication perspectives of patients engaged in long-term buprenorphine treatment that may underlie motivations to discontinue.

Rights

© 2023 by The Association for Multidisciplinary Education and Research in Substance use and Addiction (AMERSA), Inc.

DOI

10.1177/08897077231165625

Persistent Identifier

https://archives.pdx.edu/ds/psu/40568

Included in

Public Health Commons

COinS